SensoDetect specialises in the development of equipment used to analyse the reaction of sound stimulus in the brain of a patient. The technology is mainly used in psychiatry when treating patients to distinguish potential mental disorders. The product consists of electrodes that are attached to the head of the patient to analyse brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is based in Lund.

Quotes for SensoDetect AB

Right Now

+/-
0.002
%
1,77%
Latest
0.115
High
0.129
Low
0.1105
Volume
585 906
Turnover (SEK)
67 060
Market Value (MSEK)
35,1
Time (Latest trade)

Board

CEO

  • Per-Anders Hedin

Chairperson of the Board

  • Johan Möllerström

Board

  • Haqvin Svensson
  • Johan Granath
  • Jonas Hagberg
  • Pia Kinhult
  • Wendi Ma
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    SensoDetect

    SensoDetect - Presentation BioStock Live - 2018-11-27

    SensoDetect AB intervju

    Bolagspresentation

    Largest Owners

    Name Capital % Votes % Date
    Thomas Erik Frithiof Holmgren 11,86 11,86 2024-03-26
    QQM Fund Management AB 9,93 9,93 2024-03-26
    Nordnet Pensionsförsäkring 8,83 8,83 2024-03-26
    Avanza Pension 4,46 4,46 2024-03-26
    Tore Robertsson 3,13 3,13 2024-03-26
    Karl Vilhelm Gustaf Lundin 2,94 2,94 2024-03-26
    Johan Möllerström med bolag 2,81 2,81 2024-03-26
    Per-Anders Hedin 2,22 2,22 2024-03-26
    Birgitta Möllerström 2,21 2,21 2024-03-26
    Joachim Runesson 1,87 1,87 2024-03-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Upcoming reports

    • 2024-05-24 Årsstämma 2023

    • 2024-05-24 Delårsrapport 2024-Q1

    • 2024-08-30 Delårsrapport 2024-Q2

    • 2024-11-08 Delårsrapport 2024-Q3

    • 2025-02-21 Bokslutskommuniké 2024

    • 2025-05-23 Årsstämma 2024

    Annual reports, prospectus etc.